|
NSUN4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.130760E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.524950E-01 |
| Normal-vs-Stage2 |
2.584000E-01 |
| Normal-vs-Stage3 |
4.764400E-01 |
| Normal-vs-Stage4 |
3.389600E-01 |
| Stage1-vs-Stage2 |
5.359600E-01 |
| Stage1-vs-Stage3 |
1.333180E-01 |
| Stage1-vs-Stage4 |
4.730000E-01 |
| Stage2-vs-Stage3 |
1.471630E-01 |
| Stage2-vs-Stage4 |
8.588400E-01 |
| Stage3-vs-Stage4 |
1.677810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.060810E-01 |
| Normal-vs-AfricanAmerican |
6.501800E-01 |
| Normal-vs-Asian |
6.602200E-01 |
| Caucasian-vs-AfricanAmerican |
4.818800E-01 |
| Caucasian-vs-Asian |
5.471600E-01 |
| AfricanAmerican-vs-Asian |
6.989600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.294500E-02 |
| Normal-vs-Female |
8.677600E-01 |
| Male-vs-Female |
1.954590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.004200E-01 |
| Normal-vs-Extreme_Weight |
3.174800E-01 |
| Normal-vs-Obese |
4.026600E-01 |
| Normal-vs-Extreme_Obese |
2.007400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.911600E-01 |
| Normal_Weight-vs-Obese |
3.452000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.481390E-01 |
| Extreme_Weight-vs-Obese |
9.522000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.871400E-01 |
| Obese-vs-Extreme_Obese |
2.856000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.234200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.341690E-02 |
| Normal-vs-Age(61-80Yrs) |
5.952600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.961800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.226000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.704200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.739680E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.745900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.446040E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.317550E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.104020E-02 |
| Normal-VS-Type2 PRCC |
4.107000E-01 |
| Normal-VS-KIRP CIMP |
2.273600E-01 |
| Normal-VS-Unclassified PRCC |
4.870100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.960600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.489800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.913200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.347200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.320440E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.754200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.500000E-01 |
| Normal-vs-N1 |
4.527400E-01 |
| Normal-vs-N2 |
6.565200E-01 |
| N0-vs-N1 |
4.272800E-01 |
| N0-vs-N2 |
6.626200E-01 |
| N1-vs-N2 |
3.739600E-01 |
|
|
